sumatriptan

Ligand id: 54

Name: sumatriptan

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 5
Hydrogen bond donors 2
Rotatable bonds 6
Topological polar surface area 73.58
Molecular weight 295.14
XLogP 0.97
No. Lipinski's rules broken 0

Molecular properties generated using the CDK

No information available.
Summary of Clinical Use
Used in the treatment of acute migraine attacks. Oral, injectable (Zembrace SymTouch®, a pre-filled single-dose, disposable autoinjector) and inhalation (Onzetra Xsail®, sumatriptan powder delivered using the novel XsailTM breath powered delivery device) formulations of sumatriptan succinate are available.
Mechanism Of Action and Pharmacodynamic Effects
Agonist of 5-HT1B and 5-HT1D receptors. Following binding of sumatripan to these receptors, adenylate cyclase activity is inhibited, increasing intracellular calcium resulting in vasoconstriction and inhibition of sensory nocieptive nerve firing and vasoactive peptide release.
External links